News & events
December 2023 Newsletter
In this edition, read about our 2023 achievements. The newsletter also highlights our latest knowledge product, "The Market Report," offering a comprehensive overview of the markets for sexual reproductive health commodities. The Report not only sheds light on market dynamics but also presents recommendations for enhancing access to these vital SRH products.
August 2023 newsletter
June Newsletter
Data partnership with Maisha Meds
Blogs
Blog, October 2023
Empowering Women: Reflecting on the 2023 Women Deliver Conference in Kigali, Rwanda
Exploring new private market data sources to understand sexual and reproductive health markets and drive action
Events
Conference on Public Health in Africa (CPHIA) and the 28th Conference of the Parties of the United Nations Framework Convention on Climate Change (COP 28)
As the year comes to a close, SEMA eagerly anticipates its participation in the upcoming Conference on Public Health in Africa (CPHIA) and the 28th Conference of the Parties of the United Nations Framework Convention on Climate Change (COP 28).
African governments have shown remarkable commitment to promoting the growth of the sexual and reproductive health (SRH) sectors within their respective nations. We anticipate that the discussions at CPHIA will yield fruitful outcomes in exploring avenues through which stakeholders in the SRH landscape can contribute to enhancing the capacities of African countries to secure more funding for SRH.
We are also pleased to highlight that, for the first time at COP 28, there will be two dedicated days for the health agenda. This development underscores the critical importance of health for a nation's prosperity. We expect that significant attention will be paid to sexual reproductive health, recognizing its integral role in human well-being.
The annual International Conference on Public Health in Africa (CPHIA) serves as a unique African-led platform for leaders across the continent to reflect on the lessons learned in health and science and to align on a path forward for building more resilient health systems. The event is scheduled to take place from November 27 to November 30, 2023, in Lusaka, Zambia.
The 'COP' series gathers world leaders, ministers, and negotiators to address climate change and its consequences. These conferences are attended by representatives from civil society, the private sector, international organizations, and the media. This year, the 28th session of the Conference of the Parties (COP28) to the UN Framework Convention on Climate Change (UNFCCC) will be hosted at Expo City, Dubai, United Arab Emirates (UAE), from November 30 to December 12, 2023.
We believe that these two events will bring significant attention to sexual reproductive health as a pivotal factor in improving overall well-being on a global scale.
Past Events
Webinar: Countries efforts towards improving Sexual and Reproductive Health (SRH) commodities markets
In October 2023, SEMA in collaboration with CHAI, PharmAccess, RAME, and RESADE as well as Ministries of Health experts from Burkina Faso, Nigeria, and Senegal hosted a webinar to discuss findings from countries' assessment of SRH commodities markets.
The speakers provided an in-depth analysis of the obstacles related to market shaping for sexual reproductive health products at the national level. They also disclosed the concrete measures that country stakeholders are either currently implementing or planning to undertake in order to tackle these challenges.
For reference, here are the materials related to the webinar.
- The Webinar recording
- The deck presented during the webinar in English and French
- Read summary reports on SRH commodities markets for Burkina Faso, Nigeria, and Senegal
SEMA at ICFP 2022
Under the theme “Family Planning & Universal Health Coverage: Innovate. Collaborate.
SEMA at Women Deliver 2023
Our goal is to collaborate with various stakeholders, share our country and product assessments, and inspire them to organize and align efforts to drive market access.
SEMA webinar on SRH product assessments: IUD, injectables, and medical abortion
Our webinar discussed SEMA's recent product assessment findings on Hormonal IUD, injectables, and medical abortion - three critical SRH products.